E08.3312

Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC37

Diabetes with Chronic Complications

HCC298

Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage

CMS-HCC ESRD V24

HCC18

Diabetes with Chronic Complications

RxHCC V08

RXHCC30

Diabetes with Complications

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from E08.33Diabetes due to undrl cond w moderate nonprlf diabetic rtnop
7th character

One of the following 7th characters is to be assigned to codes in subcategory E08.33 to designate laterality of the disease:

Valid 7th characters and their meanings
CharacterMeaning
1right eye
2left eye
3bilateral
9unspecified eye
Inherited from E08Diabetes mellitus due to underlying condition
Excludes 1

drug or chemical induced diabetes mellitus (E09.-) gestational diabetes (O24.4-) neonatal diabetes mellitus (P70.2) postpancreatectomy diabetes mellitus (E13.-) postprocedural diabetes mellitus (E13.-) secondary diabetes mellitus NEC (E13.-) type 1 diabetes mellitus (E10.-) type 2 diabetes mellitus (E11.-)

Use additional

code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85) insulin (Z79.4) oral antidiabetic drugs (Z79.84) oral hypoglycemic drugs (Z79.84)

Code first

the underlying condition, such as: congenital rubella (P35.0) Cushing's syndrome (E24.-) cystic fibrosis (E84.-) malignant neoplasm (C00-C96) malnutrition (E40-E46) pancreatitis and other diseases of the pancreas (K85-K86.-)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases
Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E08.3312

FY 2026 ›
I.C.4Chapter-specific guidanceChapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89)

Subsections

Sections that reference E08.3312

Sections whose FY 2026 text names E08.3312, its E08 category, or a range containing it — the chapter guidance above is the authoritative source.